Heart scar on MRI may decide who gets a lifesaving shock device
NCT ID NCT07415642
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether an implantable defibrillator (ICD) can reduce the risk of sudden cardiac death in people with non-ischemic dilated cardiomyopathy, a type of heart muscle disease not caused by blocked arteries. Researchers will use MRI scans to find heart scarring (fibrosis) and then randomly assign those with scarring to either get an ICD or continue standard medication. The goal is to see if the ICD improves survival and helps doctors better predict who is at highest risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Implantable Cardioverter-Defibrillator (ICD)
What this could lead to
If successful, this could show that an ICD saves lives in certain heart muscle disease patients and help doctors better identify who needs one.
What could go wrong
The trial hasn't started yet, and it's possible that ICDs may not reduce overall death risk or that complications from the device outweigh benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUDDEN CARDIAC DEATH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radboud University Medical Center
Nijmegen, Netherlands
Contact
-
University Medical Center Groningen
Groningen, Netherlands